uniQure N.V. - Ordinary Shares (QURE): Price and Financial Metrics
QURE Price/Volume Stats
Current price | $13.21 | 52-week high | $19.18 |
Prev. close | $13.30 | 52-week low | $3.73 |
Day low | $13.16 | Volume | 126,594 |
Day high | $13.55 | Avg. volume | 1,059,052 |
50-day MA | $14.64 | Dividend yield | N/A |
200-day MA | $8.10 | Market Cap | 643.90M |
QURE Stock Price Chart Interactive Chart >
uniQure N.V. - Ordinary Shares (QURE) Company Bio
uniQure is a biopharmaceutical company, developing adeno-associated virus (AAV) based gene therapies through its technology platform for multiple therapeutic areas. The company was founded in 1998 and is based in Amsterdam, the Netherlands.
QURE Price Returns
1-mo | -0.15% |
3-mo | 112.89% |
6-mo | 99.85% |
1-year | 149.72% |
3-year | -21.79% |
5-year | -79.09% |
YTD | -25.20% |
2024 | 160.86% |
2023 | -70.14% |
2022 | 9.31% |
2021 | -42.60% |
2020 | -49.58% |
Continue Researching QURE
Want to see what other sources are saying about uniQure NV's financials and stock price? Try the links below:uniQure NV (QURE) Stock Price | Nasdaq
uniQure NV (QURE) Stock Quote, History and News - Yahoo Finance
uniQure NV (QURE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...